Published in Neurol Res on February 12, 2009
Localized 1H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and N-acetylaspartate. Arthritis Res Ther (2010) 1.02
Three-dimensional magnetic resonance spectroscopic imaging in the substantia nigra of healthy controls and patients with Parkinson's disease. Eur Radiol (2011) 0.89
Early Alzheimer's disease neuropathology detected by proton MR spectroscopy. J Neurosci (2014) 0.87
Neurochemical changes within human early blind occipital cortex. Neuroscience (2013) 0.86
Dopamine reduction in the substantia nigra of Parkinson's disease patients confirmed by in vivo magnetic resonance spectroscopic imaging. PLoS One (2014) 0.86
Quantitative proton magnetic resonance spectroscopy and spectroscopic imaging of the brain: a didactic review. Top Magn Reson Imaging (2010) 0.84
Brain changes in long-term zen meditators using proton magnetic resonance spectroscopy and diffusion tensor imaging: a controlled study. PLoS One (2013) 0.83
Cortical and subcortical glutathione levels in adults with autism spectrum disorder. Autism Res (2015) 0.76
Magnetic resonance spectroscopy in the prediction of early conversion from amnestic mild cognitive impairment to dementia: a prospective cohort study. BMJ Open (2011) 0.76
Comparative study of cerebral white matter in autism and attention-deficit/hyperactivity disorder by means of magnetic resonance spectroscopy. Acad Radiol (2005) 1.59
The contribution of magnetic resonance spectroscopy and echoplanar perfusion-weighted MRI in the initial assessment of brain tumours. J Neurooncol (2005) 1.05
Brain glutamate levels are decreased in Alzheimer's disease: a magnetic resonance spectroscopy study. Am J Alzheimers Dis Other Demen (2011) 1.00
Retinal alterations in mild cognitive impairment and Alzheimer's disease: an optical coherence tomography study. J Neurol (2014) 0.93
Evidence of brain damage after high-altitude climbing by means of magnetic resonance imaging. Am J Med (2006) 0.92
Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI. Eur J Radiol (2008) 0.91
Evidence of brain dysfunction in attention deficit-hyperactivity disorder: a controlled study with proton magnetic resonance spectroscopy. Acad Radiol (2007) 0.90
Transient encephalopathy from angiographic contrast: a rare complication in neurointerventional procedures. Cardiovasc Intervent Radiol (2009) 0.86
White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination? Acad Radiol (2006) 0.85
Magnetic resonance imaging based clinical research in Alzheimer's disease. J Alzheimers Dis (2012) 0.85
Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas. Acad Radiol (2006) 0.81
Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment. Neurol Res (2010) 0.79
Levetiracetam plasma level monitoring during pregnancy, delivery, and postpartum: clinical and outcome implications. Epilepsy Behav (2009) 0.77
Dystonia induced by gabapentin. Ann Pharmacother (2005) 0.76
Depression in the prodromal phase of Alzheimer disease and the reverse causal hypothesis. Arch Gen Psychiatry (2009) 0.75
Ataxia of Charlevoix-Saguenay: MR and Clinical Results in Lower-Limb Musculature. Can J Neurol Sci (2014) 0.75
Hematological indices, mountain sickness and MRI brain abnormalities in professional and amateur mountain climbers after altitude exposure. Neurol Res (2009) 0.75